Cornerstone Advisors (Washington)’s West Pharmaceutical WST Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$89K	Buy	324 +15	+5%	+$3.97K	0.01%	186
2020 Q2	$70K	Buy	309 +122	+65%	+$24K	0.01%	211
2020 Q1	$28K	Buy	187 +154	+467%	+$23.7K	﹤0.01%	295
2019 Q4	$5K	Buy	33 +6	+22%	+$874	﹤0.01%	503
2019 Q3	$4K	Hold	27	–	–	﹤0.01%	525
2019 Q2	$3K	Hold	27	–	–	﹤0.01%	1075
2019 Q1	$3K	Buy	27 +14	+108%	+$1.46K	﹤0.01%	950
2018 Q4	$1K	Hold	13	–	–	﹤0.01%	1122
2018 Q3	$2K	Hold	13	–	–	﹤0.01%	916
2018 Q2	$1K	Hold	13	–	–	﹤0.01%	1128
2018 Q1	$1K	Buy	+13	New	+$1.22K	﹤0.01%	1116

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Cornerstone Advisors (Washington)'s WST Position: Q3 2020 in Review

Cornerstone Advisors (Washington) increased its West Pharmaceutical (WST) stake by 4.9% in Q3 2020, buying an estimated $3.97K and bringing the position to 324 shares worth $89K. The position accounts for 0.01% of the portfolio, ranked #186.

Cornerstone Advisors (Washington) first reported a position in WST in Q1 2018 and has held it in 11 quarters since. 574 funds tracked by Wall St. Rank hold WST as of Q3 2020.

Cornerstone Advisors (Washington) held 324 shares of West Pharmaceutical worth $89K as of Q3 2020.
Cornerstone Advisors (Washington) bought 15 West Pharmaceutical shares in Q3 2020, an estimated $3.97K.
West Pharmaceutical made up 0.01% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #186 holding.
Cornerstone Advisors (Washington) first reported a position in West Pharmaceutical in Q1 2018 and has held it in 11 quarters since.
574 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.